The ezrin metastatic phenotype is associated with the initiation of protein Translation

Neoplasia

Volumn 14, Issue 4, 2012, Pages 297-310

  Briggs, Joseph W ^a   Ren, Ling ^a   Nguyen, Rachel ^a   Chakrabarti, Kristi ^a   Cassavaugh, Jessica ^a   Rahim, Said ^b   Bulut, Gulay ^b   Zhou, Ming ^c   Veenstra, Timothy D ^c   Chen, Qingrong ^a   Wei, Jun S ^a   Khan, Javed ^a   Uren, Aykut ^b   Khanna, Chand ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; INITIATION FACTOR 4E; MESSENGER RNA; POLYADENYLIC ACID BINDING PROTEIN; RECEPTOR FOR ACTIVATED C KINASE 1; RIBONUCLEOPROTEIN; RNA 18S; RNA 28S; RNA 5S; S6 KINASE; Y BOX BINDING PROTEIN 1;

5' UNTRANSLATED REGION; AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYSOME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PSEUDOPODIUM; SUCROSE DENSITY GRADIENT CENTRIFUGATION; TANDEM MASS SPECTROMETRY; TRANSLATION INITIATION; UNINDEXED SEQUENCE; WESTERN BLOTTING;

EID: 84860635862     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.111518     Document Type: Article

References (56)

1. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, and Helman LJ (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10, 182-186.
2. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, and Merlino G (2004). Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 10, 175-181.
3. Ilmonen S, Vaheri A, Asko-Seljavaara S, and Carpen O (2005). Ezrin in primary cutaneous melanoma. Mod Pathol 18, 503-510.
4. Ohtani K, Sakamoto H, Rutherford T, Chen Z, Satoh K, and Naftolin F (1999). Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett 147, 31-38.
5. Pang ST, Fang X, Valdman A, Norstedt G, Pousette A, Egevad L, and Ekman P (2004). Expression of ezrin in prostatic intraepithelial neoplasia. Urology 63, 609-612.
6. Tokunou M, Niki T, Saitoh Y, Imamura H, Sakamoto M, and Hirohashi S (2000). Altered expression of the ERM proteins in lung adenocarcinoma. Lab Invest 80, 1643-1650.
7. Tynninen O, Carpen O, Jaaskelainen J, Paavonen T, and Paetau A (2004). Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neurobiol 30, 472-477.
8. Weng WH, Ahlen J, Astrom K, Lui WO, and Larsson C (2005). Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 11, 6198-6204.
9. Bruce B, Khanna G, Ren L, Landberg G, Jirstrom K, Powell C, Borczuk A, Keller ET, Wojno KJ, Meltzer P, et al. (2007). Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis 24, 69-78.
10. Reczek D, Berryman M, and Bretscher A (1997). Identification of EBP50: a PDZcontaining phosphoprotein that associates with members of the ezrin-radixinmoesin family. J Cell Biol 139, 169-179.
11. Tsukita S, Oishi K, Sato N, Sagara J, and Kawai A (1994). ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actinbased cytoskeletons. J Cell Biol 126, 391-401.
12. Berryman M, Franck Z, and Bretscher A (1993). Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 105(pt 4), 1025-1043.
13. Bretscher A, Chambers D, Nguyen R, and Reczek D (2000). ERM-Merlin and EBP50 protein families in plasma membrane organization and function. Annu Rev Cell Dev Biol 16, 113-143.
14. + exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival. J Biol Chem 279, 26280-26286.
15. Bretscher A, Edwards K, and Fehon RG (2002). ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3, 586-599.
16. Ng T, Parsons M, Hughes WE, Monypenny J, Zicha D, Gautreau A, Arpin M, Gschmeissner S, Verveer PJ, Bastiaens PI, et al. (2001). Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J 20, 2723-2741.
17. Serrador JM, Nieto M, and Sanchez-Madrid F (1999). Cytoskeletal rearrangement during migration and activation of T lymphocytes. Trends Cell Biol 9, 228-233.
18. Ren L, Hong SH, Cassavaugh J, Osborne T, Chou AJ, Kim SY, Gorlick R, Hewitt SM, and Khanna C (2009). The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene 28, 792-802.
19. Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I, et al. (2012). Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene 31, 269-281.
20. Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, Trepel J, Meltzer P, and Helman L (2001). Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 61, 3750-3759.
21. Bretscher A, Reczek D, and Berryman M (1997). Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. J Cell Sci 110(pt 24), 3011-3018.
22. Yang HS, Cho MH, Zakowicz H, Hegamyer G, Sonenberg N, and Colburn NH (2004). A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 24, 3894-3906.
23. Wei JS and Khan J (2002). Purification of Total RNA from Mammalian Cells and Tissue. Cold Spring Harbor Laboratory Press, New York, NY.
24. Son CG, Bilke S, Davis S, Greer BT, Wei JS, Whiteford CC, Chen QR, Cenacchi N, and Khan J (2005). Database of mRNA gene expression profiles of multiple human organs. Genome Res 15, 443-450.
25. Riss J, Khanna C, Koo S, Chandramouli GV, Yang HH, Hu Y, Kleiner DE, Rosenwald A, Schaefer CF, Ben-Sasson SA, et al. (2006). Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res 66, 7216-7224.
26. Gotz S, Garcia-Gomez JM, Terol J, Williams TD, Nagaraj SH, Nueda MJ, Robles M, Talon M, Dopazo J, and Conesa A (2008). High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res 36, 3420-3435.
27. Reczek D and Bretscher A (1998). The carboxyl-terminal region of EBP50 binds to a site in the amino-terminal domain of ezrin that is masked in the dormant molecule. J Biol Chem 273, 18452-18458.
28. Wilm M, Shevchenko A, Houthaeve T, Breit S, Schweigerer L, Fotsis T, and Mann M (1996). Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 379, 466-469.
29. Graff JR and Zimmer SG (2003). Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clin Exp Metastasis 20, 265-273.
30. Parsyan A, Svitkin Y, Shahbazian D, Gkogkas C, Lasko P, Merrick WC, and). mRNA helicases: the tacticians of translational control. Nat Rev Mol Cell Biol 12, 235-245.
31. Sehgal A, Briggs J, Rinehart-Kim J, Basso J, and Bos TJ (2000). The chicken c-Jun 5′ untranslated region directs translation by internal initiation. Oncogene 19, 2836-2845.
32. Stoneley M and Willis AE (2003). Aberrant regulation of translation initiation in tumorigenesis. Curr Mol Med 3, 597-603.
33. Coyle SM, Gilbert WV, and Doudna JA (2009). Direct link between RACK1 function and localization at the ribosome in vivo. Mol Cell Biol 29, 1626-1634.
34. Nilsson J, Sengupta J, Frank J, and Nissen P (2004). Regulation of eukaryotic translation by the RACK1 protein: a platform for signalling molecules on the ribosome. EMBO Rep 5, 1137-1141.
35. Evdokimova V, Ruzanov P, Anglesio MS, Sorokin AV, Ovchinnikov LP, Buckley J, Triche TJ, Sonenberg N, and Sorensen PH (2006). Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species. Mol Cell Biol 26, 277-292.
36. Kang YK, Hong SW, Lee H, and Kim WH (2010). Prognostic implications of ezrin expression in human hepatocellular carcinoma. Mol Carcinog 49, 798-804.
37. Wei YC, Li CF, Yu SC, Chou FF, Fang FM, Eng HL, Uen YH, Tian YF, Wu JM, Li SH, et al. (2009). Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location. Mod Pathol 22, 1351-1360.
38. Elzagheid A, Korkeila E, Bendardaf R, Buhmeida A, Heikkila S, Vaheri A, Syrjanen K, Pyrhonen S, and Carpen O (2008). Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Hum Pathol 39, 1737-1743.
39. Madan R, Brandwein-Gensler M, Schlecht NF, Elias K, Gorbovitsky E, Belbin TJ, Mahmood R, Breining D, Qian H, Childs G, et al. (2006). Differential tissue and subcellular expression of ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic significance for head and neck squamous cell carcinoma. Head Neck 28, 1018-1027.
40. Kobel M, Gradhand E, Zeng K, Schmitt WD, Kriese K, Lantzsch T, Wolters M, Dittmer J, Strauss HG, Thomssen C, et al. (2006). Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma. Int J Gynecol Pathol 25, 121-130.
41. Wong CW, Lee A, Shientag L, Yu J, Dong Y, Kao G, Al-Mehdi AB, Bernhard EJ, and Muschel RJ (2001). Apoptosis: an early event in metastatic inefficiency. Cancer Res 61, 333-338.
42. Chicurel ME, Singer RH, Meyer CJ, and Ingber DE (1998). Integrin binding and mechanical tension induce movement of mRNA and ribosomes to focal adhesions. Nature 392, 730-733.
43. Kim S and Coulombe PA (2010). Emerging role for the cytoskeleton as an organizer and regulator of translation. Nat Rev Mol Cell Biol 11, 75-81.
44. Polak P, Oren A, Ben-Dror I, Steinberg D, Sapoznik S, Arditi-Duvdevany A, and Vardimon L (2006). The cytoskeletal network controls c-Jun translation in a UTR-dependent manner. Oncogene 25, 665-676.
45. Van Horck FP and Holt CE (2008). A cytoskeletal platform for local translation in axons. Sci Signal 1, pe11.
46. Willett M, Flint SA, Morley SJ, and Pain VM (2006). Compartmentalisation and localisation of the translation initiation factor (eIF) 4F complex in normally growing fibroblasts. Exp Cell Res 312, 2942-2953.
47. De Benedetti A and Graff JR (2004). eIF-4E expression and its role in malignancies and metastases. Oncogene 23, 3189-3199.
48. Livingstone M, Atas E, Meller A, and Sonenberg N (2010). Mechanisms governing the control of mRNA translation. Phys Biol 7, 021001.
49. Hsieh AC and Ruggero D (2010). Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer. Clin Cancer Res 16, 4914-4920.
50. Woods AJ, Roberts MS, Choudhary J, Barry ST, Mazaki Y, Sabe H, Morley SJ, Critchley DR, and Norman JC (2002). Paxillin associates with poly(A)-binding protein 1 at the dense endoplasmic reticulum and the leading edge of migrating cells. J Biol Chem 277, 6428-6437.
51. Woods AJ, Kantidakis T, Sabe H, Critchley DR, and Norman JC (2005). Interaction of paxillin with poly(A)-binding protein 1 and its role in focal adhesion turnover and cell migration. Mol Cell Biol 25, 3763-3773.
52. Di Cristofano C, Leopizzi M, Miraglia A, Sardella B, Moretti V, Ferrara A, Petrozza V, and Della Rocca C (2010). Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell. Mod Pathol 23, 1012-1020.
53. Batchelor CL, Woodward AM, and Crouch DH (2004). Nuclear ERM (ezrin, radixin, moesin) proteins: regulation by cell density and nuclear import. Exp Cell Res 296, 208-222.
54. Rabl J, Leibundgut M, Ataide SF, Haag A, and Ban N (2011). Crystal structure of the eukaryotic 40S ribosomal subunit in complex with initiation factor 1. Science 331, 730-736.
55. Sengupta J, Nilsson J, Gursky R, Spahn CM, Nissen P, and Frank J (2004). Identification of the versatile scaffold protein RACK1 on the eukaryotic ribosome by cryo-EM. Nat Struct Mol Biol 11, 957-962.
56. Angenstein F, Evans AM, Settlage RE, Moran ST, Ling SC, Klintsova AY, Shabanowitz J, Hunt DF, and Greenough WT (2002). A receptor for activated C kinase is part of messenger ribonucleoprotein complexes associated with polyA-mRNAs in neurons. J Neurosci 22, 8827-8837.